# AngioSafe Peripheral CTO Crossing System Study (RESTOR-1 Study)

> **NCT04663867** · NA · COMPLETED · sponsor: **AngioSafe, Inc.** · enrollment: 79 (actual)

## Conditions studied

- Peripheral Artery Occlusion
- Peripheral Arterial Disease

## Interventions

- **DEVICE:** AngioSafe Peripheral CTO Crossing System

## Key facts

- **NCT ID:** NCT04663867
- **Lead sponsor:** AngioSafe, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-03
- **Primary completion:** 2023-04-25
- **Final completion:** 2023-06-15
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2026-02-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04663867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04663867, "AngioSafe Peripheral CTO Crossing System Study (RESTOR-1 Study)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04663867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*